OMNY Health Launches Platform to Accelerate Life-Changing Innovations Through Data-Driven Insights

OMNY Health (OMNY Inc.) today announced commercial availability of the OMNY Health Platform™,  a healthcare data-sharing solution that accelerates innovation by connecting the healthcare ecosystem with opportunities to connect anonymized data with researchers from life sciences organizations. Platform clients can use this data to develop new therapies, enhance treatment availability, and measure effectiveness.

The use of anonymized real-world treatment data to support life sciences companies’ decision-making across healthcare is not new. It is, however, often done without the direct involvement of healthcare providers — the originators of the information. The OMNY Health Platform offers provider organizations of all sizes the ability to participate in data-sharing partnerships with life sciences organizations to support research activities in an efficient and compliant manner.

“As a healthcare executive focused on patient safety and quality, I was often frustrated with our inability to efficiently partner with life sciences companies to help address patients’ treatment challenges and understand unmet needs,” said Mitesh Rao MD, CEO and Founder of OMNY Health. “OMNY Health provides a trusted, compliant solution for patients and providers to build transparent and secure data-driven relationships at scale and with minimal effort.”

The OMNY Health Platform centers on de-identified, normalized electronic health record data, enhanced with tokens that support links across the data ecosystem, all while preserving patient anonymity.  A diverse set of hospitals, health systems, and specialty provider organizations have already agreed to join the network, representing care delivered in more than 39 states and more than 10 million patient lives.

The platform contains more than 100 pre-packaged searchable and downloadable data offerings, aligned to strategic therapeutic areas, drug classes, and procedure groups.  The direct-from-source data on the platform cover both inpatient and outpatient care and all payer types. OMNY can also provide custom data cuts and analyses for life sciences researchers.  Insights from these data can help better understand unmet patient needs, design more efficient clinical trials, and inform strategies to address challenges in access to care.

The number of organizations opting to participate on the data sharing platform is rapidly growing, as are the types of data being made available.

“We focused on creating a flexible, scalable architecture that supports the diverse set of data needed by life sciences organizations to meet multiple use cases across the value chain, and one that could easily integrate into their workflows,” said Sean O’Brien, co-founder and Chief Technology Officer at OMNY.  “Time and budget constraints can hinder life sciences companies from getting the information needed for faster, more-effective decision-making.  Our platform specifically addresses these challenges.”

Solution demonstrations and studies showcasing the diverse data available via the OMNY Health Platform are scheduled to be presented during a variety of events this summer, including ISPOR, DIA, and ICPE.

About OMNY Health

OMNY Health connects patients, providers, and life sciences companies through data and insights to accelerate life-changing innovation.  Our easy-to-use, secure platform enables life sciences organizations to engage in collaborative data and research partnerships efficiently, compliantly, and at scale.

The team at OMNY Health imagines a future of patient-centered and evidence-based care. We’ll achieve that mission through a seamless workflow of analysis-to-insight-to-decision-making based on a connected ecosystem of healthcare data and collaboration across the healthcare ecosystem.   

For more information visit www.omnyhealth.com or e-mail:lifesciences@omnyhealth.com.  

Total
0
Shares
Leave a Reply
Related Posts
Read More

Transitiv Customer Data Platform Raises $1.7 Million Seed Round Led by Vocap Investment Partners

Transitiv, the open platform to unify, understand, and activate customer data, announced today it has closed a $1.7 Million seed investment. The oversubscribed round was led by Vocap Investment Partners. Transitiv has already seen explosive organic growth in the latter half of 2019, with revenue and customer contract acquisition nearly tripling results for the first half of the year. The Company will use the funds to support broader market penetration, accelerate product enhancements, and hire select personnel in marketing, sales, and customer support. The round comes just weeks after Transitiv was spotlighted at Venture Atlanta 2019.

MiMedx Announces Resignation of Board Member

MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that Luis A. Aguilar has notified the Company of his resignation from the Board of Directors. The Board expresses its appreciation for his service.